Cargando…
An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
BACKGROUND: Allergic rhinitis affects around one quarter of the Western European population. Prophylactic allergen immunotherapy may be useful to reduce the risk of acute symptomatic attacks (hayfever). A five-grass pollen extract sublingual immunotherapy (5GPE-SLIT) has been developed for the treat...
Autores principales: | Blin, Patrick, Demoly, Pascal, Drouet, Martine, Falissard, Bruno, Lignot-Maleyran, Séverine, Maizi, Hélène, Lorrain, Simon, Lassalle, Régis, Droz-Perroteau, Cécile, Moore, Nicholas, Molimard, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151918/ https://www.ncbi.nlm.nih.gov/pubmed/30258465 http://dx.doi.org/10.1186/s13223-018-0262-9 |
Ejemplares similares
-
161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012) -
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017) -
Exploring novel systemic biomarker approaches in grass‐pollen sublingual immunotherapy using omics
por: Barker‐Tejeda, Tomas Clive, et al.
Publicado: (2020) -
“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015) -
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database
por: Blin, Patrick, et al.
Publicado: (2021)